Strides Arcolab’s arm Agila Biotech signs agreement with Bio X-cell

19 Mar 2013 Evaluate

Strides Arcolab’s subsidiary Agila Biotech (Malaysia) has signed a build-and-lease agreement with Bio X-cell worth RM107 million, in order to establish a customized biotech facility located in the Bio X-cell ecosystem in Nusajaya, Johar, Malaysia. Bio X-cell will fund RM67.32 million approximately to be provided under the build and lease agreement for construction of the building and part of the equipments. All other equipments and integration service and testing of this project will be funded by Agila Biotech.

The work on the project is expected to start after all necessary clearances and permits have been obtained and all supplemented agreements have been executed. The R&D and manufacturing facilities is expected to be operational by end of 2014.

Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×